Contact Us
Current Deals

Company Details

PHILIPS INDIA LIMITED

  • www.philips.co.in
  • Sector: Healthcare
  • CHRYSEUM SCORE: 8.00/10.00
    ×

    PHILIPS INDIA LIMITED

    • Sector: Healthcare
    • CHRYSEUM SCORE: 8.00/10.00

    Description: Philips India Limited is a subsidiary of Royal Philips of the Netherlands, a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care.

    Evaluation is basis the latest financial year disclosures filed by the company

    Valuation

    Max Score: 3.50

    P/E of Company

    19.15

    AVG P/E of Key Peer/s

    41.35

    Valuation Score

    3.50

    The Valuation Score depicts if the company is available at a discount when compared to its listed/unlisted peers. Higher the discount, more is the score given to the company.

    Growth

    Max Score: 3.50

    Sales Growth

    6.07%

    PAT Growth

    5.17%

    ROE

    20.76%

    Growth Score

    1.50

    The Growth Score accounts for the growth in Sales and PAT on a 3 year CAGR basis and the Company’s ROE as per the latest financial year results released by the company.

    Leverage

    Max Score: 1.50

    Debt / Equity

    0.00

    AVG Industry Debt / Equity

    0.00

    Leverage Score

    1.50

    Lower the Debt/Equity, higher the score.

    Management Quality

    Max Score: 1.50

    Board Structure & Composition

    1.00

    Related Party Transactions

    1.00

    Timely Disclosure

    1.00

    Management Score

    1.50

    This score represents a consolidated view of the Company’s Management Quality, which includes Board Structure, Related Party Transactions and Timely disclosures. Each parameter is scored out of 1.

₹1215.00 0.00 (0.00%)

As on 06 Oct, 2026
L 880.00 52 Week Range H 1215.00
Company Description : A subsidiary of Royal Philips of the Netherlands a leading health technology company focused on enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care.
Company Overview
  • Name of Company PHILIPS INDIA LIMITED
  • Sector Healthcare
  • ISIN INE319A01016
  • Scrip Code PHILIPS INDIA
  • CIN U31902WB1930PLC006663
  • Pan No AABCP9487A
  • Face Value 10
  • Price ₹ 1215.00
  • No. of Shares outstanding 5.75 Cr.
  • Market Cap ₹ 6,988.34 Cr
Financials
  • Revenue from operations ₹ 7,169.10 Cr.
  • EBITDA ₹ 689.90 Cr.
  • EBITDA Margin % 9.62%
  • Profit After Tax ₹ 364.80 Cr.
  • PAT Margin % 5.02%
  • EPS 63.42
  • Stock P/E 19.16
  • Book Value Per Share 376.95
  • P/B 3.22
  • Debt/Equity 0.00
Other Key Statistics
  • 52 week High/Low 1215.00/880.00
  • Dividend Per Share 0.00
  • Dividend Yield 0.00%
  • Sales Growth - 3 years 7.73%
  • EBITDA Growth - 3 years 13.19%
  • PAT Growth - 3 years 11.95%
  • EPS Growth - 3 years 11.94%
  • ROE 16.83%
  • ROCE 25.19%
  • Cash Equivalents 988.00
All figures below are in INR Crores unless otherwise stated

Peer Comparison

Key Financials - FY26
Company Name Philips India Siemens Ltd
Listing Status Unlisted Listed
Revenue from Operations 7,169.10 24,845.00
Total Income 7,267.70 25,598.00
Finance Cost 39.80 33.80
Depreciation & Amortization 173.00 415.10
Total Expenses 6,790.60 22,470.30
EBITDA 689.90 3,576.60
PAT 364.80 2,283.40
No. of Shares Outstanding 5.75 35.61
EPS (in ₹) 63.42 64.12
Share Capital 57.50 71.20
Total Net Worth 2,168.10 13,840.20
Total Assets 4,959.00 21,300.60
Total Debt 0.00 0.00
Key Metrics:
CMP* 1,215.00 3,643.00
Market Cap (In Cr.) 6,988.34 129,734.70
Market Cap/Sales 0.96 5.07
EPS (Earnings Per Share) 63.42 64.12
BVPS (Book Value Per Share) 376.95 388.64
P/E 19.16 56.82
P/BV 3.22 9.37
EBITDA Margin 9.62% 14.40%
ROE 16.83% 16.50%
ROA 7.36% 10.72%
*Market Price in ₹ as on 06 Oct, 2026

Profit Loss

FY26 FY25 FY24 FY23 FY22
Revenue from operations 7,169.10 6,542.00 6,000.40 5,734.00 5,481.40
Y-o-Y Revenue Growth 9.59% 9.03% 4.65% 4.61% -1.84%
Other Income 98.60 88.60 60.90 71.90 64.80
Total Income 7,267.70 6,630.60 6,061.30 5,805.90 5,546.20
Total Expenses (Excludes Interest and Depreciation) 6,577.80 5,950.80 5,553.00 5,330.20 5,147.30
Operating Profit (After deducting Depreciation) 418.30 416.50 304.80 275.30 195.70
OPM % 5.83 6.37 5.08 4.80 3.57
EBITDA 689.90 679.80 508.30 475.70 398.90
Depreciation 173.00 174.70 142.60 128.50 138.40
EBIT 516.90 505.10 365.70 347.20 260.50
Interest 39.80 57.10 38.80 26.40 27.20
EBT before Exceptional Items 477.10 448.00 326.90 320.80 233.30
Prior period/Exceptional /Extra Ordinary Items 0.00 0.00 0.00 0.00 -130.90
Profit before tax/EBT 477.10 448.00 326.90 320.80 364.20
Tax 112.30 138.70 69.40 60.80 98.30
Net Profit 364.80 309.30 257.50 260.00 265.90
Profit (loss) of minority interest 0.00 0.00 0.00 0.00 0.00
Total profit (loss) for period 364.80 309.30 257.50 260.00 265.90
EPS in Rs 63.42 53.78 44.78 45.21 46.23
EPS Change % 17.94% 20.09% -0.95% -2.21% 8.62%
EBITDA Change % 1.49% 33.74% 6.85% 19.25% -22.21%
Profit growth 17.94% 20.12% -0.96% -2.22% 8.66%
ROCE 25.19% 19.08% 15.57% 20.42% 9.42%
ROE 16.83% 17.15% 17.29% 21.06% 11.68%
Debt / Equity Ratio 0.00 0.00 0.00 0.00 0.00
Sales growth 3Years 7.73%
Sales growth 5Years 5.12%
Dividend per share 0.00 0.00 0.00 222.00 3.00

Balance Sheet

FY26 FY25 FY24 FY23 FY22
Share Capital 57.50 57.50 57.50 57.50 57.50
Reserves 2,110.60 1,746.10 1,432.10 1,176.80 2,220.00
Total shareholders' funds 2,168.10 1,803.60 1,489.60 1,234.30 2,277.50
Borrowings 0.00 0.00 0.00 0.00 0.00
Other Liabilities 371.30 290.40 327.90 313.50 257.40
Total Liabilities 2,790.90 2,268.90 2,426.10 2,005.80 2,067.40
Fixed Assets 762.10 922.90 943.10 386.00 344.10
Capital WIP 17.70 8.30 24.90 115.80 26.90
Investments 4.00 4.40 4.70 5.00 5.30
Other Assets 395.60 460.30 369.20 445.30 862.90
Total Assets 4,959.00 4,072.50 3,915.70 3,240.10 4,344.90
Cash Equivalents 988.00 247.30 272.80 211.80 1,315.90
Total Current liability 2,907.30 1,425.50 1,567.50 1,540.10 1,579.90
Total Assets -Total Current liabilty 2,051.70 2,647.00 2,348.20 1,700.00 2,765.00

Cash Flow

FY26 FY25 FY24 FY23 FY22
Net Cash from / (used in) Operating Activity 901.50 127.90 735.50 341.30 131.70
Net Cash from / (used in) Investing Activity -887.70 -63.80 -582.90 -52.90 368.20
Net Cash from / (used in) Financing Activity -102.60 -89.60 -91.70 -1,392.50 -115.30
Net Inc/Dec In Cash And Cash Equivalents -88.80 -25.50 61.00 -1,104.10 384.60

Share Holding Pattern

No. of Shares in Crs. % Holding
Promoters 5.53 96.13%
Non Promoters 0.22 3.87%

News

PHILIPS INDIA LIMITED

  • www.philips.co.in
  • Sector: Healthcare
  • CHRYSEUM SCORE: 8.00/10.00
    ×

    PHILIPS INDIA LIMITED

    • Sector: Healthcare
    • CHRYSEUM SCORE: 8.00/10.00

    Description: Philips India Limited is a subsidiary of Royal Philips of the Netherlands, a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care.

    Evaluation is basis the latest financial year disclosures filed by the company

    Valuation

    Max Score: 3.50

    P/E of Company

    19.15

    AVG P/E of Key Peer/s

    41.35

    Valuation Score

    3.50

    The Valuation Score depicts if the company is available at a discount when compared to its listed/unlisted peers. Higher the discount, more is the score given to the company.

    Growth

    Max Score: 3.50

    Sales Growth

    6.07%

    PAT Growth

    5.17%

    ROE

    20.76%

    Growth Score

    1.50

    The Growth Score accounts for the growth in Sales and PAT on a 3 year CAGR basis and the Company’s ROE as per the latest financial year results released by the company.

    Leverage

    Max Score: 1.50

    Debt / Equity

    0.00

    AVG Industry Debt / Equity

    0.00

    Leverage Score

    1.50

    Lower the Debt/Equity, higher the score.

    Management Quality

    Max Score: 1.50

    Board Structure & Composition

    1.00

    Related Party Transactions

    1.00

    Timely Disclosure

    1.00

    Management Score

    1.50

    This score represents a consolidated view of the Company’s Management Quality, which includes Board Structure, Related Party Transactions and Timely disclosures. Each parameter is scored out of 1.

₹1215.00 0.00 (0.00%)

As on 06 Oct, 2026
L 880.00 52 Week Range H 1215.00
Company Description : A subsidiary of Royal Philips of the Netherlands a leading health technology company focused on enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care.
Company Overview
  • Name of Company PHILIPS INDIA LIMITED
  • Sector Healthcare
  • ISIN INE319A01016
  • Scrip Code PHILIPS INDIA
  • CIN U31902WB1930PLC006663
  • Pan No AABCP9487A
  • Face Value 10
  • Price ₹ 1215.00
  • No. of Shares outstanding 5.75 Cr.
  • Market Cap ₹ 6,988.34 Cr
Financials
  • Revenue from operations ₹ 7,169.10 Cr.
  • EBITDA ₹ 689.90 Cr.
  • EBITDA Margin % 9.62%
  • Profit After Tax ₹ 364.80 Cr.
  • PAT Margin % 5.02%
  • EPS 63.42
  • Stock P/E 19.16
  • Book Value Per Share 376.95
  • P/B 3.22
  • Debt/Equity 0.00
Other Key Statistics
  • 52 week High/Low 1215.00/880.00
  • Dividend Per Share 0.00
  • Dividend Yield 0.00%
  • Sales Growth - 3 years 7.73%
  • EBITDA Growth - 3 years 13.19%
  • PAT Growth - 3 years 11.95%
  • EPS Growth - 3 years 11.94%
  • ROE 16.83%
  • ROCE 25.19%
  • Cash Equivalents 988.00
All figures below are in INR Crores unless otherwise stated

Peer Comparison

Key Financials - FY26
Company Name Philips India Siemens Ltd
Listing Status Unlisted Listed
Revenue from Operations 7,169.10 24,845.00
Total Income 7,267.70 25,598.00
Finance Cost 39.80 33.80
Depreciation & Amortization 173.00 415.10
Total Expenses 6,790.60 22,470.30
EBITDA 689.90 3,576.60
PAT 364.80 2,283.40
No. of Shares Outstanding 5.75 35.61
EPS (in ₹) 63.42 64.12
Share Capital 57.50 71.20
Total Net Worth 2,168.10 13,840.20
Total Assets 4,959.00 21,300.60
Total Debt 0.00 0.00
Key Metrics:
CMP* 1,215.00 3,643.00
Market Cap (In Cr.) 6,988.34 129,734.70
Market Cap/Sales 0.96 5.07
EPS (Earnings Per Share) 63.42 64.12
BVPS (Book Value Per Share) 376.95 388.64
P/E 19.16 56.82
P/BV 3.22 9.37
EBITDA Margin 9.62% 14.40%
ROE 16.83% 16.50%
ROA 7.36% 10.72%
*Market Price in ₹ as on 06 Oct, 2026

Profit Loss

FY26 FY25 FY24 FY23 FY22
Revenue from operations 7,169.10 6,542.00 6,000.40 5,734.00 5,481.40
Y-o-Y Revenue Growth 9.59% 9.03% 4.65% 4.61% -1.84%
Other Income 98.60 88.60 60.90 71.90 64.80
Total Income 7,267.70 6,630.60 6,061.30 5,805.90 5,546.20
Total Expenses (Excludes Interest and Depreciation) 6,577.80 5,950.80 5,553.00 5,330.20 5,147.30
Operating Profit (After deducting Depreciation) 418.30 416.50 304.80 275.30 195.70
OPM % 5.83 6.37 5.08 4.80 3.57
EBITDA 689.90 679.80 508.30 475.70 398.90
Depreciation 173.00 174.70 142.60 128.50 138.40
EBIT 516.90 505.10 365.70 347.20 260.50
Interest 39.80 57.10 38.80 26.40 27.20
EBT before Exceptional Items 477.10 448.00 326.90 320.80 233.30
Prior period/Exceptional /Extra Ordinary Items 0.00 0.00 0.00 0.00 -130.90
Profit before tax/EBT 477.10 448.00 326.90 320.80 364.20
Tax 112.30 138.70 69.40 60.80 98.30
Net Profit 364.80 309.30 257.50 260.00 265.90
Profit (loss) of minority interest 0.00 0.00 0.00 0.00 0.00
Total profit (loss) for period 364.80 309.30 257.50 260.00 265.90
EPS in Rs 63.42 53.78 44.78 45.21 46.23
EPS Change % 17.94% 20.09% -0.95% -2.21% 8.62%
EBITDA Change % 1.49% 33.74% 6.85% 19.25% -22.21%
Profit growth 17.94% 20.12% -0.96% -2.22% 8.66%
ROCE 25.19% 19.08% 15.57% 20.42% 9.42%
ROE 16.83% 17.15% 17.29% 21.06% 11.68%
Debt / Equity Ratio 0.00 0.00 0.00 0.00 0.00
Sales growth 3Years 7.73%
Sales growth 5Years 5.12%
Dividend per share 0.00 0.00 0.00 222.00 3.00

Balance Sheet

FY26 FY25 FY24 FY23 FY22
Share Capital 57.50 57.50 57.50 57.50 57.50
Reserves 2,110.60 1,746.10 1,432.10 1,176.80 2,220.00
Total shareholders' funds 2,168.10 1,803.60 1,489.60 1,234.30 2,277.50
Borrowings 0.00 0.00 0.00 0.00 0.00
Other Liabilities 371.30 290.40 327.90 313.50 257.40
Total Liabilities 2,790.90 2,268.90 2,426.10 2,005.80 2,067.40
Fixed Assets 762.10 922.90 943.10 386.00 344.10
Capital WIP 17.70 8.30 24.90 115.80 26.90
Investments 4.00 4.40 4.70 5.00 5.30
Other Assets 395.60 460.30 369.20 445.30 862.90
Total Assets 4,959.00 4,072.50 3,915.70 3,240.10 4,344.90
Cash Equivalents 988.00 247.30 272.80 211.80 1,315.90
Total Current liability 2,907.30 1,425.50 1,567.50 1,540.10 1,579.90
Total Assets -Total Current liabilty 2,051.70 2,647.00 2,348.20 1,700.00 2,765.00

Cash Flow

FY26 FY25 FY24 FY23 FY22
Net Cash from / (used in) Operating Activity 901.50 127.90 735.50 341.30 131.70
Net Cash from / (used in) Investing Activity -887.70 -63.80 -582.90 -52.90 368.20
Net Cash from / (used in) Financing Activity -102.60 -89.60 -91.70 -1,392.50 -115.30
Net Inc/Dec In Cash And Cash Equivalents -88.80 -25.50 61.00 -1,104.10 384.60

Share Holding Pattern

No. of Shares in Crs. % Holding
Promoters 5.53 96.13%
Non Promoters 0.22 3.87%

News

India’s First Private Market Benchmark. Providing institutional clarity to the unlisted securities market.

  • +91 98925 31672
  • info@chryseum.in
  • For latest updates
  • © 2026 Chryseum Advisors LLP. All rights reserved. LLPIN – AAD-0626